Amgen

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Amgen 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About AMGN

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. 

CEO
Robert A. Bradway
CEORobert A. Bradway
Employees
31,500
Employees31,500
Headquarters
Thousand Oaks, California
HeadquartersThousand Oaks, California
Founded
1980
Founded1980
Employees
31,500
Employees31,500

AMGN Key Statistics

Market cap
177.79B
Market cap177.79B
Price-Earnings ratio
22.52
Price-Earnings ratio22.52
Dividend yield
2.98%
Dividend yield2.98%
Average volume
2.81M
Average volume2.81M
High today
$329.66
High today$329.66
Low today
$320.53
Low today$320.53
Open price
$322.01
Open price$322.01
Volume
3.32M
Volume3.32M
52 Week high
$391.29
52 Week high$391.29
52 Week low
$261.43
52 Week low$261.43

Stock Snapshot

The current Amgen(AMGN) stock price is $328.62, with a market capitalization of 177.79B. The stock trades at a price-to-earnings (P/E) ratio of 22.52 and offers a dividend yield of 3.0%.

On 2026-05-05, Amgen(AMGN) stock traded between a low of $320.53 and a high of $329.66. Shares are currently priced at $328.62, which is +2.5% above the low and -0.3% below the high.

The Amgen(AMGN)'s current trading volume is 3.32M, compared to an average daily volume of 2.81M.

During the past year, Amgen(AMGN) stock moved between $261.43 at its lowest and $391.29 at its peak.

During the past year, Amgen(AMGN) stock moved between $261.43 at its lowest and $391.29 at its peak.

AMGN News

Investor's Business Daily 10h
Can This Small Rival Take On Amgen's Eye Disease Blockbuster?

Technology Can This Small Rival Take On Amgen's Eye Disease Blockbuster? Licensing Viridian Therapeutics (VRDN) on Tuesday unveiled promising results for its ex...

Can This Small Rival Take On Amgen's Eye Disease Blockbuster?
TipRanks 12h
Erste downgrades Amgen on declining sales growth

Erste Group analyst Hans Engel downgraded Amgen (AMGN) to Hold from Buy, saying the company’s sales growth will likely decline in 2026 and 2027. Amgen’s growth...

Simply Wall St 17h
A Look At Amgen Valuation After Q1 Beat And US$300m Puerto Rico Expansion

Amgen (AMGN) is back in focus after a busy few weeks, with Q1 2026 earnings above market estimates, higher full year revenue guidance, and a fresh US$300 millio...

A Look At Amgen Valuation After Q1 Beat And US$300m Puerto Rico Expansion

Analyst ratings

51%

of 37 ratings
Buy
40.5%
Hold
51.4%
Sell
8.1%

More AMGN News

Nasdaq 1d
Amgen To Invest Additional $300 Mln In US Manufacturing Network

(RTTNews) - Amgen Inc. (AMGN) Monday revealed its plan to invest an additional $300 million in its U.S. manufacturing network to further advance U.S.-based prod...

Amgen To Invest Additional $300 Mln In US Manufacturing Network
Simply Wall St 3d
Did Amgen’s Raised 2026 Outlook and AI-Focused Overhaul Just Shift AMGN’s Investment Narrative?

In the past week, Amgen reported first-quarter 2026 results showing revenue of US$8,618 million and net income of US$1,819 million, with both basic and diluted...

Did Amgen’s Raised 2026 Outlook and AI-Focused Overhaul Just Shift AMGN’s Investment Narrative?
TipRanks 4d
Amgen Earnings Call Highlights Growth Engines, Tax Risk

Amgen Inc ((AMGN)) has held its Q1 earnings call. Read on for the main highlights of the call. Claim 55% Off TipRanks Unlock hedge fund-level data and powerful...

Nasdaq 4d
Why the S&P 500 and Nasdaq Hit Record Highs While the Dow Fell Today

Key Points The S&P 500 and Nasdaq 100 hit fresh records Friday morning; the Dow turned negative by midday. Apple's 4.5% post-earnings jump is carrying the tec...

Why the S&P 500 and Nasdaq Hit Record Highs While the Dow Fell Today
TipRanks 4d
Amgen Price Target Raised to $425 as Strong Execution and Expanding Pipeline Underpin Maintained Buy Rating

Goldman Sachs analyst Salveen Richter maintained a Buy rating on Amgen today and set a price target of $425.00. Unlock hedge fund-level data and powerful inves...

Nasdaq 4d
Nasdaq 100 Movers: AMGN, DDOG

In early trading on Friday, shares of Datadog topped the list of the day's best performing components of the Nasdaq 100 index, trading up 5.1%. Year to date, Da...

Nasdaq 100 Movers: AMGN, DDOG
Nasdaq 4d
Dow Movers: AMGN, AAPL

In early trading on Wednesday, shares of Apple topped the list of the day's best performing Dow Jones Industrial Average components, trading up 0.6%. Year to da...

Dow Movers: AMGN, AAPL

People also own

Based on the portfolios of people who own AMGN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.